ACTIVE SUBSTANCE / INN

POTASSIUM ACETATE

Brand name(s): FREAMINE III 8.5% W/ ELECTROLYTES, PLASMA-LYTE 56 IN PLASTIC CONTAINER, AMINOSYN 3.5% M IN PLASTIC CONTAINER, AMINOSYN II 3.5% M IN PLASTIC CONTAINER, VEINAMINE 8%, AMINOSYN 3.5% M, POTASSIUM ACETATE, AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER, PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA016822
ANDA206203
ACTIVE SUBSTANCE
Potassium Acetate
REGULATORS
FDA
SPONSORS / MAH
EXELA PHARMA, HOSPIRA, ICU MEDICAL INC
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PLASMA-LYTE 56 IN PLASTIC CONTAINERNDA019047BAXTER HLTHCAREDiscontinued
POTASSIUM ACETATEANDA206203EXELA PHARMADiscontinued
VEINAMINE 8%NDA017957HOSPIRA INCDiscontinued
AMINOSYN 3.5% M IN PLASTIC CONTAINERNDA018875ABBOTTDiscontinued
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINERNDA017385BAXTER HLTHCAREDiscontinued
POTASSIUM ACETATENDA018896HOSPIRAPrescription
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINERNDA019682HOSPIRA INCDiscontinued
AMINOSYN 3.5% MNDA017789ICU MEDICAL INCDiscontinued
AMINOSYN II 3.5% M IN PLASTIC CONTAINERNDA019493ABBOTTDiscontinued
FREAMINE III 8.5% W/ ELECTROLYTESNDA016822B BRAUNDiscontinued

FULL INTELLIGENCE ON POTASSIUM ACETATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →